Target intelligence / Profile preview

Deltastream DP3 diagonal-flow pump (DP3)

Target
DP3
Molecular classification
Other (Mechanical medical device; not a biological molecule or protein)
01

Overview

The Deltastream DP3 diagonal-flow pump (commonly called the DP3 or Medos DP3) is a third-generation mechanical blood pump designed for use in extracorporeal life support (ECLS) applications, including pediatric and neonatal ECMO. The device is characterized by a pivot-mounted, magnetically driven, shrouded impeller with four flat blades, combining features of axial and centrifugal pumps (“diagonal-flow”)[1][3][9]. It is capable of providing pulsatile or nonpulsatile flow, with a priming volume as low as 16–18 mL, and supports flow rates up to 8 L/min (in adult configurations) and lower ranges for pediatric/neonatal setups[1][2][3][5][8][9]. The DP3 can generate physiological pulsatile flow, which may improve hemodynamics compared to nonpulsatile pumps, though it does not directly interact with biological molecules or act as a pharmacological target[1][2][4][5]. Safety concerns include hemolysis, thrombosis risks, and possible mechanical wear. The device is not a pharmaceutical or biological target, and thus does not have molecular function, drug interactions, disease roles, or biomarker associations in the sense typical of drug targets[3][8].

Other names
Medos Deltastream DP3Xenios DP3DP3-i-cor diagonal pump
02

Mechanism of action

Provides extracorporeal blood flow and supports circulation by imparting artificial pulsatile/continuous flow

03

Safety considerations

Risk of blood trauma (hemolysis) due to high shear stresses and turbulent flowPotential for thrombus (clot) formation and embolism from disturbed or retrograde flow regionsWear and spallation of mechanical components, risk of particle release in bloodHemolysis risk possibly increased at higher RPMs compared to some competing pumps

Beyond the preview

Go deeper on Deltastream DP3 diagonal-flow pump (DP3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Deltastream DP3 diagonal-flow pump (DP3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call